Canadian biotechnology developer QLT slashes workforce by two-thirds, CEO to ...
News | 09 July 2012
VANCOUVER - Canadian biotechnology company QLT Inc. is cutting its workforce by two-thirds, leaving it with 68 employees after a downsizing brought in.
Click on the link to read the full article at CanadianBusiness.com
(This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
